TrialAlzheimer's research & therapy2016

Safety and tolerability of BAN2401--a clinical study in Alzheimer's disease with a protofibril selective Aβ antibody.

Veronika Logovinsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.